These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28224974)

  • 21. Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
    Mancini GB; Farkouh ME; Brooks MM; Chaitman BR; Boden WE; Vlachos H; Hartigan PM; Siami FS; Sidhu MS; Bittner V; Frye R; Fuster V
    J Am Coll Cardiol; 2016 Sep; 68(10):985-95. PubMed ID: 27585501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease.
    Ferrari R; Abergel H; Ford I; Fox KM; Greenlaw N; Steg PG; Hu D; Tendera M; Tardif JC;
    Int J Cardiol; 2013 Sep; 167(6):2938-43. PubMed ID: 22985742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
    Chieffo A; Tanaka A; Giustino G; Briede I; Sawaya FJ; Daemen J; Kawamoto H; Meliga E; D'Ascenzo F; Cerrato E; Stefanini GG; Capodanno D; Mangiameli A; Templin C; Erglis A; Morice MC; Mehran R; Van Mieghem NM; Nakamura S; De Benedictis M; Pavani M; Varbella F; Pisaniello M; Sharma SK; Tamburino C; Tchetche D; Colombo A;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2401-2410. PubMed ID: 29217002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation in Patients With Severe Left Ventricular Dysfunction.
    Kang SH; Lee CW; Baek S; Lee PH; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2017 Jul; 120(1):69-74. PubMed ID: 28483202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of left ventricular systolic dysfunction on secondary medical prevention and clinical outcome in stable coronary artery disease patients.
    Lamblin N; Meurice T; Tricot O; Lemesle G; Deneve M; de Groote P; Bauters C
    Arch Cardiovasc Dis; 2017 Jan; 110(1):35-41. PubMed ID: 27591820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Geographical differences in clinical characteristics and management of stable outpatients with coronary artery disease: comparison between the Italian and international population included in the Worldwide CLARIFY registry].
    Pozzoli M; Tavazzi L
    G Ital Cardiol (Rome); 2014 Apr; 15(4):226-32. PubMed ID: 24873811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists.
    Bittencourt MS; Christman MP; Hulten E; Divakaran S; Skali H; Kwong RY; Hainer J; Forman DE; Kirshenbaum JM; Dorbala S; Di Carli MF; Blankstein R
    Am J Cardiol; 2014 Jul; 114(2):305-11. PubMed ID: 24874162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study.
    De Luca L; Temporelli PL; Riccio C; Gonzini L; Marinacci L; Tartaglione SN; Costa P; Scherillo M; Senni M; Colivicchi F; Gulizia MM;
    Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):334-342. PubMed ID: 30649303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry).
    Reinecke H; Breithardt G; Engelbertz C; Schmieder RE; Fobker M; Pinnschmidt HO; Schmitz B; Bruland P; Wegscheider K; Pavenstädt H; Brand E
    PLoS One; 2016; 11(2):e0148057. PubMed ID: 26859890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual antiplatelet therapy in patients with stable coronary artery disease in modern practice: prevalence, correlates, and impact on prognosis (from the Suivi d'une cohorte de patients COROnariens stables en region NORd-Pas-de-Calais study).
    Lemesle G; Lamblin N; Meurice T; Tricot O; Lallemant R; Nugue O; Delomez M; Equine O; Tondeux S; Bauters C
    Am Heart J; 2014 Oct; 168(4):479-86. PubMed ID: 25262257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in clinical characteristics, medical management, risk factor control, and long-term outcome of patients with stable coronary artery disease: from the CORONOR registry.
    Madika AL; Lemesle G; Lamblin N; Meurice T; Tricot O; Mounier-Vehier C; Bauters C
    Panminerva Med; 2019 Dec; 61(4):432-438. PubMed ID: 30311758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
    Tendera M; Fox K; Ferrari R; Ford I; Greenlaw N; Abergel H; Macarie C; Tardif JC; Vardas P; Zamorano J; Gabriel Steg P;
    Int J Cardiol; 2014 Sep; 176(1):119-24. PubMed ID: 25042656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specialty-Based Variability in Diagnosing and Managing Heart Failure With Preserved Ejection Fraction.
    Saxon DT; Kennel PJ; Guyer HM; Goyal P; Hummel SL; Konerman MC
    Mayo Clin Proc; 2020 Apr; 95(4):669-675. PubMed ID: 32247341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.
    Kang SH; Ahn JM; Lee CH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics, treatment and 2-year outcomes in Malaysian and Bruneian patients with stable coronary artery within the worldwide CLARIFY registry.
    Chee KH; Choo GH; Jamaluddin ANB; Mahendran K; Greenlaw N; Chandran A
    Med J Malaysia; 2017 Oct; 72(5):282-285. PubMed ID: 29197883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
    Taguchi I; Iimuro S; Iwata H; Takashima H; Abe M; Amiya E; Ogawa T; Ozaki Y; Sakuma I; Nakagawa Y; Hibi K; Hiro T; Fukumoto Y; Hokimoto S; Miyauchi K; Yamazaki T; Ito H; Otsuji Y; Kimura K; Takahashi J; Hirayama A; Yokoi H; Kitagawa K; Urabe T; Okada Y; Terayama Y; Toyoda K; Nagao T; Matsumoto M; Ohashi Y; Kaneko T; Fujita R; Ohtsu H; Ogawa H; Daida H; Shimokawa H; Saito Y; Kimura T; Inoue T; Matsuzaki M; Nagai R
    Circulation; 2018 May; 137(19):1997-2009. PubMed ID: 29735587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.